It could very well be ( something I've believed for a while) - they're hoping to time this with other news, whether it be uplist, BP partnering, or data on CD12. There's a reason that they're sitting on this. Behavior change in sputtering out piecemeal news has shifted. Something's up. And I think it's really good.